Topical, antimicrobial composition facilitates wound healing and prevents infections without causing irritation

Antimicrobial formulations are essential components of personal care and veterinary products, medical supplies, and household cleaning agents. Oftentimes though, these agents cause adverse health effects, such as skin, eye, or lung irritation. This technology presents an antimicrobial formulation that demonstrates reduced irritant effects while offering protection against a broad microbial spectrum. This therapeutic exhibits rapid and sustained anti-inflammatory effects without causing sensitivity to exposed tissue.

Gentle, but effective antimicrobial formulation works as anti-irritant for combination therapy, expanding the scope of applications

This technology outlines a variety of anti-microbial formulations containing zinc and various botanical compounds. These compositions offer sustained control of a wide range of surface wound infections while also enhancing the wound healing process. The formulations tested can be used for a variety of anti-inflammation, antimicrobial, or anti-bacterial purposes and can easily be included in a diverse array of topical products, including personal care creams or wound healing ointments.

This technology has shown to treat the infection that causes bovine mastitis and the inflammation that accompanies the disease.

Lead Inventor:

Shanta M. Modak, Ph.D..

Applications:

• Topical ointment for burn treatment
• Antimicrobial treatment for medicinal purposes
• Anti-irritant skin cream
• Therapeutic for veterinary purposes, as this technology has been shown to treat cow mastitis
• Personal care products designed for oral or topical applications
• Sensors for reconnaissance

Advantages:

• Sustained and rapid anti-microbial protection against a broad microbial spectrum
• Controls a wide range of surface infections to facilitate deep and minor wound healing
• Anti-inflammatory, anti-irritant that does not cause exposed tissue sensitivity

Patent information:

Patent Pending (US20130230609)

Tech Ventures Reference: IR CU2450, CU2466, CU2712, CU2441